Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04125186 · ClinicalTrials.gov registry record
A Cross-Functional, Population-Representative, Web-Based, Epidemiologic Study to Estimate the Prevalence and Burden of Nocturia Due to Nocturnal Polyuria in the US
A clinical trial, sponsored by Ferring Pharmaceuticals.
- Completed
- Registry status
- 10,190
- Enrollment target
NCT04125186 is a clinical trial that has completed, run by Ferring Pharmaceuticals. The registered enrollment target is 10,190 participants.
The verdict
NCT04125186 has completed, sponsored by Ferring Pharmaceuticals.
- COMPLETED
- Registry status
- 10,190 participants
- Enrollment target
Study Summary
To estimate the prevalence of nocturia due to nocturnal polyuria (NP) in the US and describe the demographic and clinical characteristics as well as the burden of illness in participants with nocturia due to NP.
Interventions
- DIAGNOSTIC_TEST Baseline EpiNP survey
- DIAGNOSTIC_TEST Bladder diary
- DIAGNOSTIC_TEST Testing of EpiNP baseline survey, bladder diary and a qualitative interview
- OTHER No other intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,190 participants |
| Start Date | 2019-07-22 |
| Est. Completion | 2020-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04125186
The ClinicalTrials.gov registry entry for NCT04125186 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10,190 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ferring Pharmaceuticals, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Baseline EpiNP survey is the first listed.
NCT04125186 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04125186 about?
NCT04125186 is a clinical study titled "A Cross-Functional, Population-Representative, Web-Based, Epidemiologic Study to Estimate the Prevalence and Burden of Nocturia Due to Nocturnal Polyuria in the US". To estimate the prevalence of nocturia due to nocturnal polyuria (NP) in the US and describe the demographic and clinical characteristics as well as the burden of illness in participants with nocturia due to NP.
What is the current status of trial NCT04125186?
This trial is currently completed. The enrollment target is 10,190 participants. The study started on 2019-07-22. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT04125186?
The interventions under investigation include: Baseline EpiNP survey (DIAGNOSTIC_TEST), Bladder diary (DIAGNOSTIC_TEST), Testing of EpiNP baseline survey, bladder diary and a qualitative interview (DIAGNOSTIC_TEST), No other intervention (OTHER).
Who is sponsoring clinical trial NCT04125186?
This trial is sponsored by Ferring Pharmaceuticals, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.